Amicus Other Non Cash Items vs Capital Expenditures Analysis

FOLD Stock  USD 9.36  0.79  7.78%   
Amicus Therapeutics financial indicator trend analysis is way more than just evaluating Amicus Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Amicus Therapeutics is a good investment. Please check the relationship between Amicus Therapeutics Other Non Cash Items and its Capital Expenditures accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amicus Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For information on how to trade Amicus Stock refer to our How to Trade Amicus Stock guide.

Other Non Cash Items vs Capital Expenditures

Other Non Cash Items vs Capital Expenditures Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Amicus Therapeutics Other Non Cash Items account and Capital Expenditures. At this time, the significance of the direction appears to have almost no relationship.
The correlation between Amicus Therapeutics' Other Non Cash Items and Capital Expenditures is 0.19. Overlapping area represents the amount of variation of Other Non Cash Items that can explain the historical movement of Capital Expenditures in the same time period over historical financial statements of Amicus Therapeutics, assuming nothing else is changed. The correlation between historical values of Amicus Therapeutics' Other Non Cash Items and Capital Expenditures is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Non Cash Items of Amicus Therapeutics are associated (or correlated) with its Capital Expenditures. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Expenditures has no effect on the direction of Other Non Cash Items i.e., Amicus Therapeutics' Other Non Cash Items and Capital Expenditures go up and down completely randomly.

Correlation Coefficient

0.19
Relationship DirectionPositive 
Relationship StrengthInsignificant

Other Non Cash Items

Capital Expenditures

Capital Expenditures are funds used by Amicus Therapeutics to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Amicus Therapeutics operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.
Most indicators from Amicus Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Amicus Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amicus Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For information on how to trade Amicus Stock refer to our How to Trade Amicus Stock guide.At present, Amicus Therapeutics' Issuance Of Capital Stock is projected to decrease significantly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 4.6 B, whereas Sales General And Administrative To Revenue is forecasted to decline to 1.19.
 2023 2024 (projected)
Extraordinary Items90K85.5K
Reconciled Depreciation7.0M6.3M

Amicus Therapeutics fundamental ratios Correlations

0.85-0.610.490.690.580.880.40.760.490.650.630.490.720.590.620.460.530.490.870.550.630.850.690.930.49
0.85-0.340.370.470.380.590.080.520.70.380.790.220.520.440.330.420.370.240.730.490.340.830.480.620.26
-0.61-0.34-0.03-0.99-0.98-0.78-0.83-0.94-0.25-0.87-0.29-0.9-0.97-0.89-0.970.27-0.89-0.88-0.28-0.84-0.95-0.67-0.98-0.61-0.94
0.490.37-0.030.1-0.110.45-0.130.280.20.370.07-0.050.110.030.090.590.0-0.110.62-0.010.120.260.10.52-0.02
0.690.47-0.990.10.980.840.80.970.340.880.380.881.00.90.96-0.160.890.850.390.850.940.741.00.670.92
0.580.38-0.98-0.110.980.740.820.910.30.810.350.890.970.890.94-0.310.890.880.240.860.920.690.970.550.93
0.880.59-0.780.450.840.740.680.910.260.860.330.680.840.670.810.360.640.640.780.590.810.70.830.930.67
0.40.08-0.83-0.130.80.820.680.77-0.260.74-0.020.860.780.650.81-0.170.650.720.230.580.80.350.80.510.76
0.760.52-0.940.280.970.910.910.770.340.940.30.820.960.870.920.020.850.750.540.820.90.710.970.760.88
0.490.7-0.250.20.340.30.26-0.260.340.210.630.010.370.410.210.060.390.170.310.490.190.620.340.240.27
0.650.38-0.870.370.880.810.860.740.940.210.10.830.870.820.850.030.790.610.470.780.840.590.890.690.85
0.630.79-0.290.070.380.350.33-0.020.30.630.10.250.420.340.350.00.270.470.320.370.380.860.360.40.15
0.490.22-0.9-0.050.880.890.680.860.820.010.830.250.860.860.92-0.350.830.830.150.820.90.620.860.530.88
0.720.52-0.970.111.00.970.840.780.960.370.870.420.860.90.94-0.130.880.830.410.850.920.771.00.680.9
0.590.44-0.890.030.90.890.670.650.870.410.820.340.860.90.84-0.270.990.710.260.970.80.690.890.520.96
0.620.33-0.970.090.960.940.810.810.920.210.850.350.920.940.84-0.260.820.930.280.771.00.710.940.660.87
0.460.420.270.59-0.16-0.310.36-0.170.020.060.030.0-0.35-0.13-0.27-0.26-0.3-0.410.82-0.31-0.230.02-0.150.5-0.32
0.530.37-0.890.00.890.890.640.650.850.390.790.270.830.880.990.82-0.30.710.220.950.770.620.880.480.98
0.490.24-0.88-0.110.850.880.640.720.750.170.610.470.830.830.710.93-0.410.710.110.640.940.680.820.530.74
0.870.73-0.280.620.390.240.780.230.540.310.470.320.150.410.260.280.820.220.110.210.30.510.390.860.2
0.550.49-0.84-0.010.850.860.590.580.820.490.780.370.820.850.970.77-0.310.950.640.210.730.70.850.430.91
0.630.34-0.950.120.940.920.810.80.90.190.840.380.90.920.81.0-0.230.770.940.30.730.730.920.680.83
0.850.83-0.670.260.740.690.70.350.710.620.590.860.620.770.690.710.020.620.680.510.70.730.730.690.55
0.690.48-0.980.11.00.970.830.80.970.340.890.360.861.00.890.94-0.150.880.820.390.850.920.730.650.91
0.930.62-0.610.520.670.550.930.510.760.240.690.40.530.680.520.660.50.480.530.860.430.680.690.650.49
0.490.26-0.94-0.020.920.930.670.760.880.270.850.150.880.90.960.87-0.320.980.740.20.910.830.550.910.49
Click cells to compare fundamentals

Amicus Therapeutics Account Relationship Matchups

Amicus Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets850.2M886.5M905.1M724.2M777.9M451.1M
Total Stockholder Equity476.4M286.4M307.4M123.0M160.2M168.7M
Retained Earnings(1.8B)(2.0B)(2.3B)(2.5B)(2.7B)(2.5B)
Other Assets51.3M65.4M47.4M42.2M48.6M41.8M
Common Stock Shares Outstanding240.4M258.9M271.4M289.1M295.2M309.9M
Liabilities And Stockholders Equity850.2M886.5M905.1M724.2M777.9M473.3M
Other Stockholder Equity2.2B2.3B2.6B2.7B2.8B3.0B
Total Liab373.8M600.1M597.8M601.1M617.7M648.6M
Other Current Liab1.3M87.7M103.5M100.6M123.5M129.7M
Total Current Liabilities128.8M129.7M146.0M139.0M167.7M176.1M
Accounts Payable120.4M17.1M21.5M15.4M15.1M21.1M
Cash142.8M163.2M245.2M148.8M247.0M259.3M
Short Term Investments309.9M320.0M237.3M144.8M39.2M37.2M
Other Current Assets20.0M59.4M69.7M40.2M49.5M52.0M
Common Stock2.6M2.7M2.8M2.8M2.9M3.1M
Property Plant Equipment47.7M43.9M42.5M30.8M35.4M37.2M
Short Long Term Debt Total210.2M441.7M440.1M452.1M445.1M467.3M
Other Liab41.9M35.6M19.1M18.5M21.3M20.2M
Property Plant And Equipment Net81.0M67.2M63.1M60.3M58.0M60.9M
Net Debt67.4M278.5M194.9M303.3M198.1M208.0M
Non Current Assets Total330.1M307.1M308.3M300.4M294.8M204.5M
Non Currrent Assets Other28.3M19.1M24.4M10.0M18.6M19.5M
Long Term Debt149.5M389.3M389.4M392.0M387.9M407.3M
Cash And Short Term Investments452.7M483.3M482.5M293.6M286.2M251.3M
Common Stock Total Equity2.6M2.7M2.8M2.8M3.2M3.4M
Non Current Liabilities Total245.0M470.5M451.8M462.1M450.0M243.4M
Property Plant And Equipment Gross81.0M67.2M83.0M82.6M83.4M87.6M
Total Current Assets520.1M579.5M596.8M423.8M483.1M293.7M
Accumulated Other Comprehensive Income2.8M8.2M5.0M(12.1M)5.2M5.5M
Net Tangible Assets255.6M65.6M86.6M(97.8M)(112.4M)(106.8M)
Net Receivables33.3M46.9M52.7M66.2M87.6M92.0M
Retained Earnings Total Equity(1.8B)(2.0B)(2.3B)(2.5B)(2.3B)(2.2B)
Capital Surpluse2.2B2.3B2.6B2.7B3.1B1.7B
Inventory14.0M19.6M26.8M23.8M59.7M62.7M
Deferred Long Term Liab14.0M12.3M10.8M9.6M8.6M8.2M
Non Current Liabilities Other81.5M68.9M51.6M60.5M13.3M12.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Amicus Therapeutics is a strong investment it is important to analyze Amicus Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Amicus Therapeutics' future performance. For an informed investment choice regarding Amicus Stock, refer to the following important reports:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amicus Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For information on how to trade Amicus Stock refer to our How to Trade Amicus Stock guide.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amicus Therapeutics. If investors know Amicus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amicus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.34)
Revenue Per Share
1.629
Quarterly Revenue Growth
0.367
Return On Assets
0.0116
Return On Equity
(0.67)
The market value of Amicus Therapeutics is measured differently than its book value, which is the value of Amicus that is recorded on the company's balance sheet. Investors also form their own opinion of Amicus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Amicus Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amicus Therapeutics' market value can be influenced by many factors that don't directly affect Amicus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amicus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amicus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amicus Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.